Anthem (ANTM) PT Raised to $391 at Morgan Stanley

Go back to Anthem (ANTM) PT Raised to $391 at Morgan Stanley

Anthem (ANTM) PT Raised to $325 at Citi

February 4, 2019 6:11 AM EST

Citi analyst Ralph Giacobbe raised the price target on Anthem (NYSE: ANTM) to $325.00 (from $292.00) while maintaining a Neutral rating.

... More

Anthem (ANTM) PT Raised to $346 at RBC Capital

January 31, 2019 6:37 AM EST

RBC Capital analyst Frank Morgan raised the price target on Anthem (NYSE: ANTM) to $346.00 (from $318.00) while maintaining a Outperform rating following results.

The analyst notes strong momentum in "core" business; accelerated IngenioRx launch a significant win.

... More

Anthem (ANTM) PT Raised to $350 at Stephens

January 31, 2019 5:59 AM EST

Stephens analyst Scott Fidel raised the price target on Anthem (NYSE: ANTM) to $350.00 (from $310.00) while maintaining a Overweight rating.

... More

Anthem (ANTM) PT Raised to $330 at Barclays

January 31, 2019 5:02 AM EST

Barclays raised its price target on Anthem (NYSE: ANTM) to $330.00 (from $305.00) while maintaining a Overweight rating.

... More

Anthem (ANTM) PT Raised to $344 at Credit Suisse

January 31, 2019 4:54 AM EST

Credit Suisse analyst A.J. Rice raised the price target on Anthem (NYSE: ANTM) to $344.00 (from $330.00) while maintaining a Outperform rating.

... More

Anthem (ANTM) PT Raised to $360 at Wells Fargo

January 30, 2019 2:29 PM EST

Wells Fargo analyst Peter Costa raised the price target on Anthem (NYSE: ANTM) to $360.00 (from $314.00) while maintaining a Outperform rating.

... More

Anthem (ANTM) PT Raised to $360 at Cantor Fitzgerald

January 30, 2019 10:48 AM EST

Cantor Fitzgerald analyst Steven Halper raised the price target on Anthem (NYSE: ANTM) to $360.00 (from $330.00) while maintaining a Overweight rating.

... More

Anthem (ANTM) Tops Q4 EPS by 25c, Miss on Revenues; Offers FY19 EPS/Revenue Guidance Above Consensus

January 30, 2019 6:02 AM EST

Anthem (NYSE: ANTM) reported Q4 EPS of $2.44, $0.25 better than the analyst estimate of $2.19. Revenue for the quarter came in at $23.373 billion versus the consensus estimate of $23.38 billion.

Fourth quarter net income was $1.61 per share, including net negative adjustment items of $0.83 per share. Adjusted net income was $2.44 per share.Full year net income was $14.19 per share, including net negative adjustment items of $1.70 per share. Adjusted net income was $15.89 per share.Medical enrollment increased by 37 thousand members sequentially to 39.9 million members.Operating gain grew by 30% year-over-year to $5.4 billion in... More